Bullish option flow detected in ImmunoGen with 3,224 calls trading, 2x expected, and implied vol increasing over 11 points to 72.50%. Jul-23 20 calls and Jul-23 17 puts are the most active options, with total volume in those strikes near 2,900 contracts. The Put/Call Ratio is 0.38. Earnings are expected on July 28th.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on IMGN:
- ImmunoGen call volume above normal and directionally bullish
- ImmunoGen price target raised to $21 from $15 at H.C. Wainwright
- ImmunoGen Rises on Promising Phase 3 Elahere Data in Ovarian Cancer
- ImmunoGen announces $200M common stock offering
- ImmunoGen upgraded to Overweight at Piper after ‘overwhelmingly positive’ data